Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

US Food and Drug Administration; FDA.

Confusing labeling can affect safe medication preparation and administration. This safety announcement reviews case reports associated with inconsistent drug strength information that contributed to dosing errors of compounded injectable products.